Ausgabe 6/2023
Inhalt (10 Artikel)
The Future of Advanced Therapies for Pediatric Crohn’s Disease
Julie Gallagher, Joel R. Rosh, Benjamin Sahn
Scope of JAK Inhibitors in Children: Recent Evidence and Way Forward
Narendra Kumar Bagri, Christine Chew, A. V. Ramanan
Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease
Christopher Towe, Alexei A. Grom, Grant S. Schulert
Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options
Nicholas Chiang, Cathryn Sibbald, Rebecca Levy, Irene Lara-Corrales
Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
Yoni E. van Dijk, Niels W. Rutjes, Korneliusz Golebski, Havva Şahin, Simone Hashimoto, Anke-Hilse Maitland-van der Zee, Susanne J. H. Vijverberg
Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit
Reuth Nir, Francesca Sperotto, Manasee Godsay, Minmin Lu, John N. Kheir
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)
Alba Rubio-San-Simón, Natasha K. A. van Eijkelenburg, Raoull Hoogendijk, Henrik Hasle, Charlotte M. Niemeyer, Michael N. Dworzak, Marco Zecca, Marta Lopez-Yurda, Julie M. Janssen, Alwin D. R. Huitema, Marry M. van den Heuvel-Eibrink, Eric J. Laille, Harm van Tinteren, Christian M. Zwaan
Respiratory Syncytial Virus Prefusion F Subunit Vaccine: First Approval of a Maternal Vaccine to Protect Infants
Yahiya Y. Syed